Comparing telerehabilitation and conventional rehabilitation in chronic obstructive pulmonary disease (COPD)

Assessment of the effects of telerehabilitation in patients with chronic obstructive pulmonary disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN87158217

Enrollment

100

Registered

2025-07-22

Start date

2023-06-01

Completion date

Unknown

Last updated

2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Assessment of the effects of rehabilitation and telerehabilitation in patients with chronic obstructive pulmonary disease Respiratory

Interventions

The research included 100 patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). Qualification for pulmonary rehabilitation was carried out in Specialist MSWiA Hospital in Glucholazy im

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Clinically stable COPD diagnosis 2. Age over 18 years 3. Ability to participate in the rehabilitation programme 4. Patient’s informed and voluntary consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Inability to give informed consent 2. Significant cognitive functions’ disorders preventing independent functioning 3. Other medical contraindications to participation in the rehabilitation programme

Design outcomes

Primary

Measure	Time frame
1. Pulmonary ventilation function - Spirometry - baseline and post 3 weeks 2. Exercise capacity - 6-minute walk test (6MWT) - baseline and post 3 weeks 3. Dyspnoea - on the 10-point Borg scale- baseline and post 6-minute walk test (6MWT) 4. Saturation - pulse oximeter - baseline and post 6-minute walk test (6MWT) 5. Overall performance - Sit-to-Stand test- baseline and post 3 weeks	—

Secondary

Measure	Time frame
1. Energy expenditure, assessed based on MET values obtained during the 6-minute walk test (6MWT), measured at baseline and after 3 weeks of rehabilitation. 2. FEV1/FVC ratio, assessed using spirometry, measured at baseline and after 3 weeks of rehabilitation. 3. Level of dyspnoea, assessed using the 10-point Borg scale after the 6MWT, measured at baseline and after 3 weeks of rehabilitation. 4. Oxygen saturation (SpO2), assessed using pulse oximetry after the 6MWT, measured at baseline and after 3 weeks of rehabilitation. 5. Lower limb strength, assessed using the Sit-to-Stand test, measured before and after 3 weeks of rehabilitation.	—

Measure

Time frame

1. Energy expenditure, assessed based on MET values obtained during the 6-minute walk test (6MWT), measured at baseline and after 3 weeks of rehabilitation. 2. FEV1/FVC ratio, assessed using spirometry, measured at baseline and after 3 weeks of rehabilitation. 3. Level of dyspnoea, assessed using the 10-point Borg scale after the 6MWT, measured at baseline and after 3 weeks of rehabilitation. 4. Oxygen saturation (SpO2), assessed using pulse oximetry after the 6MWT, measured at baseline and after 3 weeks of rehabilitation. 5. Lower limb strength, assessed using the Sit-to-Stand test, measured before and after 3 weeks of rehabilitation.

—

Countries

Poland

Contacts

Public ContactKatarzyna Bogacz

k.bogacz@po.edu.pl+48 501550714

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026